Life Sciences Investors delivered a 40.59% NAV return in 2025, supported by innovation-focused biotechnology. Read the full ...

Analysts consider AtaiBeckley’s MDMA candidate a “high-risk, high-reward” bet after the drug demonstrated reductions in ...

Pivotal Phase 2 trial of RP-A501 for Danon disease to resume in 1H 2026KRESLADI™ for severe LAD-I on track for March 28, 2026 ...

If 2025 had a theme for the Charlotte region's life sciences ecosystem, it was this: years of planning finally meeting their moment. From landmark facility openings to record-breaking workforce ...

Come to the Biotech Career & Futures Fair, where representatives of top biotech and biopharmaceutical companies will discuss their current and future job openings. The event is open to all Wake Tech ...

A trusted leader who offered a steady hand and strong leadership on an interim basis in an ever-changing research environment, Sharon Paynter, Ph.D., has been named Senior Vice Provost for Research ...

PharmAla Biotech Holdings Inc. (CSE: MDMA)(OTCQB: MDXXF), a biotechnology company focused on the research, development, and ...

Tempus AI maintains strong Q4 momentum, with robust testing stats and improving financials despite recent post-earnings stock ...

AI begins transforming precision oncology, speeding drug target discovery with AlphaFold and cutting clinical trial paperwork from months to days.

The plan raises a number of questions, including how the payments will be distributed across large teams of staffers.

Upon successful development, SK bioscience with its Consortium partners plan to pursue entry into major advanced markets, including Europe's Northern Hemisphere market, and explore additional business ...

Cannara Biotech Inc. ('Cannara”, 'the Company”, 'us” or 'we”) (TSXV: LOVE) (OTCQX: LOVFF) (FRA: 8CB0), a vertically integrated producer of premium-grade cannabis products at affordable prices with two ...